Provided by Tiger Fintech (Singapore) Pte. Ltd.

Geron

1.35
+0.07505.91%
Volume:7.75M
Turnover:10.46M
Market Cap:856.64M
PE:-4.98
High:1.41
Open:1.27
Low:1.27
Close:1.27
Loading ...

Is Geron Corporation (GERN) the Best NASDAQ Penny Stock to Buy Right Now?

Insider Monkey
·
11 Dec 2024

Geron Announces New Imerge Analyses Presented at Ash Suggesting Clinical Activity of Rytelo™ (Imetelstat) in Patients With Lower-Risk Mds Regardless of Type or Number of Prior Therapies

THOMSON REUTERS
·
10 Dec 2024

Geron Announces Phase 1 Findings From Two-Part Improvemf Study Presented at Ash Suggesting Tolerability of Rytelo™ (Imetelstat) in Combination With Ruxolitinib as Frontline Therapy in Patients With Myelofibrosis

THOMSON REUTERS
·
10 Dec 2024

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies

Business Wire
·
10 Dec 2024

Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis

Business Wire
·
10 Dec 2024

Geron Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Dec 2024

Scotiabank Reaffirms Their Buy Rating on Geron (GERN)

TIPRANKS
·
09 Dec 2024

Analysts Offer Insights on Healthcare Companies: Geron (GERN), Merus (MRUS) and C4 Therapeutics (CCCC)

TIPRANKS
·
09 Dec 2024

Geron Q4 revenue estimate raised above consensus at Barclays

TIPRANKS
·
01 Dec 2024

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Business Wire
·
27 Nov 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
22 Nov 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
22 Nov 2024

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.
·
22 Nov 2024

Geron Corporation Announces Appointment of Joseph Eid, M.d. as Executive Vice President, Research and Development

THOMSON REUTERS
·
12 Nov 2024

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development

Business Wire
·
12 Nov 2024

Geron to Participate in the Stifel 2024 Healthcare Conference

Business Wire
·
11 Nov 2024

TD Cowen Reaffirms Their Buy Rating on Geron (GERN)

TIPRANKS
·
11 Nov 2024

Geron: Strong Sales Momentum and Strategic Financial Decisions Support ‘Buy’ Rating

TIPRANKS
·
11 Nov 2024

Stifel Nicolaus Remains a Buy on Geron (GERN)

TIPRANKS
·
11 Nov 2024

Geron Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
09 Nov 2024